We are monitoring the impact of COVID-19 on APAC Biomarkers Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 167
Share on
Share on

Asia Pacific Biomarkers Market Research Report – Segmented By Product, By Type, By Disease Indications & By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Analysis on Size, Share, Trends, Growth, Forecast | 2019 – 2024

Pulished: August, 2019
ID: 167
Pages: 145

The size of the APAC Biomarkers Market is predicted to reach USD 12.15 billion by 2024 from USD 5.74 billion in 2019 growing at a CAGR of 16.20% during the forecast period 2019 -2024.

The high incidence of cancer drives research programs is majorly propelling the demand for the market.

Sedentary lifestyles, unhealthy eating habits, and an increasing burden of chronic illnesses (particularly cancer, diabetes, and cardiovascular disease) due to lack of exercise are key drivers of market growth. Focusing on early detection and prevention of diseases is expected to further promote the onset of diseases.

For example, biomolecules can be analyzed to track brain health and activity, so that biomarkers can be applied in the treatment of various neurological disorders. The development of new ones, such as biomarker signatures, has improved the treatment rate of neurological diseases, leading to early diagnosis, non-invasive detection, and rapid drug development.

However, the low adoption of advanced biomarkers tests and the high cost of biomarkers developments & validation are restraining the growth of the biomarkers market in the Asia-Pacific region. The high capital expenditures, high costs of testing and the need for low profit-to-cost ratios limit the APAC Biomarkers Market growth. The unfavorable policies by both private and public organizations are challenges in the APAC Biomarkers Market growth.

The Asia Pacific region is expected to grow at a significant compound annual growth rate of over 16.0% during the forecast period. Some factors contributing to growth include the presence of key biomarker participants in the region, strategic planning for joint product development, and increased R & D investment in developing countries. In emerging countries, the cost of clinical trials is relatively lower than in developed countries, which is expected to have a positive impact on expansion.

Noteworthy companies operating in the Asia Pacific Biomarkers Market profiled in this report are Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Enzo Biochem (U.S.), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France) and Signosis, Inc. (U.S.)

  1. Introduction

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

  1. Market Segmentation

                5.1          Product                                               

                                5.1.1 Introduction                                           

                                5.1.2 Consumables                                         

                                5.1.3 Software                                  

                                5.1.4 Services     Growth Hormone Therapy                         

                5.2          Type                                     

                                5.2.1 Introduction                                           

                                5.2.2 Safety Biomarkers                                               

                                5.2.3 Efficacy Biomarkers                                             

                                5.2.4 Validation Biomarkers                                        

                5.3          Application                                        

                                5.3.1 Introduction                                           

                                5.3.2 Diagnostics Development                                 

                                5.3.3 Drug Discovery and Development                                

                                5.3.4 Personalised Medicine                                      

                                5.3.5 Disease Risk Assessment                                  

                                5.3.6 Other Applications                                               

                5.4          Disease Indications                                        

                                5.4.1 Introduction                                           

                                5.4.2 Cancer                                      

                                5.4.3 CardiovascularDisorders                                    

                                5.4.4 Neurological Disorders                                       

                                5.4.5 Immunological Disorders                                  

                                5.4.6 Other Diseases                                      

  1. Geographical Analysis

                6.3 Asia-Pacific                                                 

                                6.1 Introduction                                               

                                6.2 China                                             

                                6.3 India                                              

                                6.4 Japan                                            

  1. Strategic Analysis

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

  1. Market Leaders' Analysis

                8.1 Bio-Rad Laboratories (U.S.)                                 

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Qiagen N.V. (Netherlands)                                  

                8.3 Enzo Biochem (U.S.)                                               

                8.4 PerkinElmer, Inc. (U.S.)                                         

                8.5 Merck & Co, Inc. (U.S.)                                          

                8.6 EKF Diagnostics Holdings plc. (U.S.)                                  

                8.7 Meso Scale Diagnostics, LLC (U.S.)                                    

                8.8 Singulex, Inc. (U.S.)                                 

                8.9 BioSims Technologies (France)                                           

                8.10 Cisbio Bioassays (France)                                   

                8.11 Signosis, Inc. (U.S.)                                               

  1. Competitive Landscape

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 


  1. List of Tables
  2. List of Figures
  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Biomarkers Market By Region, From 2019-2024 ( USD Billion )
  2. Asia-Pacific Biomarkers Market By Product, From 2019-2024 ( USD Billion )
  3. Asia-Pacific Consumables Market By Region, From 2019-2024 ( USD Billion )
  4. Asia-Pacific Software Market By Region, From 2019-2024 ( USD Billion )
  5. Asia-Pacific Services Market By Region, From 2019-2024 ( USD Billion )
  6. Asia-Pacific Biomarkers Market By Type, From 2019-2024 ( USD Billion )
  7. Asia-Pacific Safety Biomarkers Market By Region, From 2019-2024 ( USD Billion )
  8. Asia-Pacific Efficacy Biomarkers Market By Region, From 2019-2024 ( USD Billion )
  9. Asia-Pacific Validation Biomarkers Market By Region, From 2019-2024 ( USD Billion )
  10. Asia-Pacific Biomarkers Market By Application, From 2019-2024 ( USD Billion )
  11. Asia-Pacific Diagnostics Development Market By Region, From 2019-2024 ( USD Billion )
  12. Asia-Pacific Drug Discovery and Development Market By Region, From 2019-2024 ( USD Billion )
  13. Asia-Pacific Personalised Medicine Market By Region, From 2019-2024 ( USD Billion )
  14. Asia-Pacific Disease Risk Assessment Market By Region, From 2019-2024 ( USD Billion )
  15. Asia-Pacific Other Applications Market By Region, From 2019-2024 ( USD Billion )
  16. Asia-Pacific Biomarkers Market By Disease Indications, From 2019-2024 ( USD Billion )
  17. Asia-Pacific Cancer Market By Region, From 2019-2024 ( USD Billion )
  18. Asia-Pacific Cardiovascular Disorders Market By Region, From 2019-2024 ( USD Billion )
  19. Asia-Pacific Neurological Disorders Market By Region, From 2019-2024 ( USD Billion )
  20. Asia-Pacific Immunological Disorders Market By Region, From 2019-2024 ( USD Billion )
  21. Asia-Pacific Other Diseases Market By Region, From 2019-2024 ( USD Billion )
  22. China Biomarkers Market By Product, From 2019-2024 ( USD Billion )
  23. China Biomarkers Market By Type, From 2019-2024 ( USD Billion )
  24. China Biomarkers Market By Application, From 2019-2024 ( USD Billion )
  25. China Biomarkers Market By Disease Indications, From 2019-2024 ( USD Billion )
  26. India Biomarkers Market By Product, From 2019-2024 ( USD Billion )
  27. India Biomarkers Market By Type, From 2019-2024 ( USD Billion )
  28. India Biomarkers Market By Application, From 2019-2024 ( USD Billion )
  29. India Biomarkers Market By Disease Indications, From 2019-2024 ( USD Billion )
  30. Japan Biomarkers Market By Product, From 2019-2024 ( USD Billion )
  31. Japan Biomarkers Market By Type, From 2019-2024 ( USD Billion )
  32. Japan Biomarkers Market By Application, From 2019-2024 ( USD Billion )
  33. Japan Biomarkers Market By Disease Indications, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample